Global Pet Vaccine Market Growth 2025-2031
The global Pet Vaccine market size is predicted to grow from US$ 4032 million in 2025 to US$ 6176 million in 2031; it is expected to grow at a CAGR of 7.4% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pet vaccines are biological preparations designed to stimulate an immune response in pets, protecting them from infectious diseases caused by viruses, bacteria, and other pathogens. These vaccines help prevent severe illnesses such as rabies, distemper, parvovirus, and feline leukemia, reducing mortality rates and improving the overall health of companion animals. Vaccination is a crucial aspect of preventive veterinary care and is commonly administered to dogs, cats, and other domesticated animals based on specific vaccination schedules.
With advancements in veterinary medicine, modern pet vaccines are becoming more effective, safer, and tailored to specific breeds and regional disease risks. Innovations such as recombinant vaccines and mRNA-based vaccines are enhancing immune responses with fewer side effects. As pet ownership rises globally and awareness of animal health increases, the demand for high-quality pet vaccines continues to grow, supporting both public health and animal welfare.
Market Drivers:
The pet vaccine market is primarily driven by the increasing pet ownership worldwide and a growing awareness of animal health and preventive care. As more people adopt pets, the demand for vaccines to protect them from infectious diseases rises, especially with the expansion of the pet care industry. Moreover, advancements in veterinary vaccines, including more effective and safer vaccines, are improving vaccination outcomes and encouraging wider use. Public health initiatives and regulations, such as rabies vaccination requirements, also play a role in fueling market growth. Additionally, rising disposable incomes, particularly in emerging markets, are enabling pet owners to spend more on veterinary care, including vaccinations.
Market Challenges:
One of the major challenges facing the pet vaccine market is the high cost of some vaccines, which can be a barrier to regular vaccination, especially for pet owners in lower-income regions. Furthermore, the increasing complexity of vaccine schedules and the need for specialized veterinary care may slow down adoption rates in some areas. In addition, the emergence of counterfeit or low-quality vaccines poses a significant threat to market growth and animal health. Regulatory barriers and inconsistencies across different regions can also hinder the efficient distribution and accessibility of vaccines, especially in emerging markets with less-developed veterinary infrastructure.
LP Information, Inc. (LPI) ' newest research report, the “Pet Vaccine Industry Forecast” looks at past sales and reviews total world Pet Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Pet Vaccine sales for 2025 through 2031. With Pet Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Pet Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pet Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pet Vaccine market?
What factors are driving Pet Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet Vaccine market opportunities vary by end market size?
How does Pet Vaccine break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pet vaccines are biological preparations designed to stimulate an immune response in pets, protecting them from infectious diseases caused by viruses, bacteria, and other pathogens. These vaccines help prevent severe illnesses such as rabies, distemper, parvovirus, and feline leukemia, reducing mortality rates and improving the overall health of companion animals. Vaccination is a crucial aspect of preventive veterinary care and is commonly administered to dogs, cats, and other domesticated animals based on specific vaccination schedules.
With advancements in veterinary medicine, modern pet vaccines are becoming more effective, safer, and tailored to specific breeds and regional disease risks. Innovations such as recombinant vaccines and mRNA-based vaccines are enhancing immune responses with fewer side effects. As pet ownership rises globally and awareness of animal health increases, the demand for high-quality pet vaccines continues to grow, supporting both public health and animal welfare.
Market Drivers:
The pet vaccine market is primarily driven by the increasing pet ownership worldwide and a growing awareness of animal health and preventive care. As more people adopt pets, the demand for vaccines to protect them from infectious diseases rises, especially with the expansion of the pet care industry. Moreover, advancements in veterinary vaccines, including more effective and safer vaccines, are improving vaccination outcomes and encouraging wider use. Public health initiatives and regulations, such as rabies vaccination requirements, also play a role in fueling market growth. Additionally, rising disposable incomes, particularly in emerging markets, are enabling pet owners to spend more on veterinary care, including vaccinations.
Market Challenges:
One of the major challenges facing the pet vaccine market is the high cost of some vaccines, which can be a barrier to regular vaccination, especially for pet owners in lower-income regions. Furthermore, the increasing complexity of vaccine schedules and the need for specialized veterinary care may slow down adoption rates in some areas. In addition, the emergence of counterfeit or low-quality vaccines poses a significant threat to market growth and animal health. Regulatory barriers and inconsistencies across different regions can also hinder the efficient distribution and accessibility of vaccines, especially in emerging markets with less-developed veterinary infrastructure.
LP Information, Inc. (LPI) ' newest research report, the “Pet Vaccine Industry Forecast” looks at past sales and reviews total world Pet Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Pet Vaccine sales for 2025 through 2031. With Pet Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pet Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Pet Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pet Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pet Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pet Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pet Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Nasal Administration
- Injection
- Other
- Cat
- Dog
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Boehringer Ingelheim
- Zoetis
- Elanco Animal Health
- Merck Animal Health
- Virbac
- Dechra Veterinary Products
- Ceva
- Vetoquinol
- Meiji
- Ouro Fino Saude
- Animalcare Group
- Parnell
- CAHIC
- Ringpu
- Jinyu Group
- Keqian Biology
- Kyoritsu Seiyaku
What is the 10-year outlook for the global Pet Vaccine market?
What factors are driving Pet Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pet Vaccine market opportunities vary by end market size?
How does Pet Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Fibrin Sealant (Human) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Fibrin Sealant (Human) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Fibrin Sealant (Human) by Country/Region, 2020, 2024 & 2031
2.2 Fibrin Sealant (Human) Segment by Type
2.2.1 2mL/Set
2.2.2 4mL/Set
2.2.3 10mL/Set
2.3 Fibrin Sealant (Human) Sales by Type
2.3.1 Global Fibrin Sealant (Human) Sales Market Share by Type (2020-2025)
2.3.2 Global Fibrin Sealant (Human) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Fibrin Sealant (Human) Sale Price by Type (2020-2025)
2.4 Fibrin Sealant (Human) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Fibrin Sealant (Human) Sales by Application
2.5.1 Global Fibrin Sealant (Human) Sale Market Share by Application (2020-2025)
2.5.2 Global Fibrin Sealant (Human) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Fibrin Sealant (Human) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Fibrin Sealant (Human) Breakdown Data by Company
3.1.1 Global Fibrin Sealant (Human) Annual Sales by Company (2020-2025)
3.1.2 Global Fibrin Sealant (Human) Sales Market Share by Company (2020-2025)
3.2 Global Fibrin Sealant (Human) Annual Revenue by Company (2020-2025)
3.2.1 Global Fibrin Sealant (Human) Revenue by Company (2020-2025)
3.2.2 Global Fibrin Sealant (Human) Revenue Market Share by Company (2020-2025)
3.3 Global Fibrin Sealant (Human) Sale Price by Company
3.4 Key Manufacturers Fibrin Sealant (Human) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fibrin Sealant (Human) Product Location Distribution
3.4.2 Players Fibrin Sealant (Human) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FIBRIN SEALANT (HUMAN) BY GEOGRAPHIC REGION
4.1 World Historic Fibrin Sealant (Human) Market Size by Geographic Region (2020-2025)
4.1.1 Global Fibrin Sealant (Human) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Fibrin Sealant (Human) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Fibrin Sealant (Human) Market Size by Country/Region (2020-2025)
4.2.1 Global Fibrin Sealant (Human) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Fibrin Sealant (Human) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Fibrin Sealant (Human) Sales Growth
4.4 APAC Fibrin Sealant (Human) Sales Growth
4.5 Europe Fibrin Sealant (Human) Sales Growth
4.6 Middle East & Africa Fibrin Sealant (Human) Sales Growth
5 AMERICAS
5.1 Americas Fibrin Sealant (Human) Sales by Country
5.1.1 Americas Fibrin Sealant (Human) Sales by Country (2020-2025)
5.1.2 Americas Fibrin Sealant (Human) Revenue by Country (2020-2025)
5.2 Americas Fibrin Sealant (Human) Sales by Type (2020-2025)
5.3 Americas Fibrin Sealant (Human) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fibrin Sealant (Human) Sales by Region
6.1.1 APAC Fibrin Sealant (Human) Sales by Region (2020-2025)
6.1.2 APAC Fibrin Sealant (Human) Revenue by Region (2020-2025)
6.2 APAC Fibrin Sealant (Human) Sales by Type (2020-2025)
6.3 APAC Fibrin Sealant (Human) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Fibrin Sealant (Human) by Country
7.1.1 Europe Fibrin Sealant (Human) Sales by Country (2020-2025)
7.1.2 Europe Fibrin Sealant (Human) Revenue by Country (2020-2025)
7.2 Europe Fibrin Sealant (Human) Sales by Type (2020-2025)
7.3 Europe Fibrin Sealant (Human) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Fibrin Sealant (Human) by Country
8.1.1 Middle East & Africa Fibrin Sealant (Human) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Fibrin Sealant (Human) Revenue by Country (2020-2025)
8.2 Middle East & Africa Fibrin Sealant (Human) Sales by Type (2020-2025)
8.3 Middle East & Africa Fibrin Sealant (Human) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fibrin Sealant (Human)
10.3 Manufacturing Process Analysis of Fibrin Sealant (Human)
10.4 Industry Chain Structure of Fibrin Sealant (Human)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fibrin Sealant (Human) Distributors
11.3 Fibrin Sealant (Human) Customer
12 WORLD FORECAST REVIEW FOR FIBRIN SEALANT (HUMAN) BY GEOGRAPHIC REGION
12.1 Global Fibrin Sealant (Human) Market Size Forecast by Region
12.1.1 Global Fibrin Sealant (Human) Forecast by Region (2026-2031)
12.1.2 Global Fibrin Sealant (Human) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Fibrin Sealant (Human) Forecast by Type (2026-2031)
12.7 Global Fibrin Sealant (Human) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Fibrin Sealant (Human) Product Portfolios and Specifications
13.1.3 Baxter Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Fibrin Sealant (Human) Product Portfolios and Specifications
13.2.3 CSL Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Fibrin Sealant (Human) Product Portfolios and Specifications
13.3.3 Bayer Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Grifols
13.4.1 Grifols Company Information
13.4.2 Grifols Fibrin Sealant (Human) Product Portfolios and Specifications
13.4.3 Grifols Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Grifols Main Business Overview
13.4.5 Grifols Latest Developments
13.5 Octapharma
13.5.1 Octapharma Company Information
13.5.2 Octapharma Fibrin Sealant (Human) Product Portfolios and Specifications
13.5.3 Octapharma Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Octapharma Main Business Overview
13.5.5 Octapharma Latest Developments
13.6 Shanghai RAAS
13.6.1 Shanghai RAAS Company Information
13.6.2 Shanghai RAAS Fibrin Sealant (Human) Product Portfolios and Specifications
13.6.3 Shanghai RAAS Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Shanghai RAAS Main Business Overview
13.6.5 Shanghai RAAS Latest Developments
13.7 Hualan Biological
13.7.1 Hualan Biological Company Information
13.7.2 Hualan Biological Fibrin Sealant (Human) Product Portfolios and Specifications
13.7.3 Hualan Biological Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hualan Biological Main Business Overview
13.7.5 Hualan Biological Latest Developments
13.8 Immuno
13.8.1 Immuno Company Information
13.8.2 Immuno Fibrin Sealant (Human) Product Portfolios and Specifications
13.8.3 Immuno Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Immuno Main Business Overview
13.8.5 Immuno Latest Developments
13.9 Behringwerke
13.9.1 Behringwerke Company Information
13.9.2 Behringwerke Fibrin Sealant (Human) Product Portfolios and Specifications
13.9.3 Behringwerke Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Behringwerke Main Business Overview
13.9.5 Behringwerke Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Fibrin Sealant (Human) Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Fibrin Sealant (Human) by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Fibrin Sealant (Human) by Country/Region, 2020, 2024 & 2031
2.2 Fibrin Sealant (Human) Segment by Type
2.2.1 2mL/Set
2.2.2 4mL/Set
2.2.3 10mL/Set
2.3 Fibrin Sealant (Human) Sales by Type
2.3.1 Global Fibrin Sealant (Human) Sales Market Share by Type (2020-2025)
2.3.2 Global Fibrin Sealant (Human) Revenue and Market Share by Type (2020-2025)
2.3.3 Global Fibrin Sealant (Human) Sale Price by Type (2020-2025)
2.4 Fibrin Sealant (Human) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Fibrin Sealant (Human) Sales by Application
2.5.1 Global Fibrin Sealant (Human) Sale Market Share by Application (2020-2025)
2.5.2 Global Fibrin Sealant (Human) Revenue and Market Share by Application (2020-2025)
2.5.3 Global Fibrin Sealant (Human) Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Fibrin Sealant (Human) Breakdown Data by Company
3.1.1 Global Fibrin Sealant (Human) Annual Sales by Company (2020-2025)
3.1.2 Global Fibrin Sealant (Human) Sales Market Share by Company (2020-2025)
3.2 Global Fibrin Sealant (Human) Annual Revenue by Company (2020-2025)
3.2.1 Global Fibrin Sealant (Human) Revenue by Company (2020-2025)
3.2.2 Global Fibrin Sealant (Human) Revenue Market Share by Company (2020-2025)
3.3 Global Fibrin Sealant (Human) Sale Price by Company
3.4 Key Manufacturers Fibrin Sealant (Human) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Fibrin Sealant (Human) Product Location Distribution
3.4.2 Players Fibrin Sealant (Human) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR FIBRIN SEALANT (HUMAN) BY GEOGRAPHIC REGION
4.1 World Historic Fibrin Sealant (Human) Market Size by Geographic Region (2020-2025)
4.1.1 Global Fibrin Sealant (Human) Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Fibrin Sealant (Human) Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Fibrin Sealant (Human) Market Size by Country/Region (2020-2025)
4.2.1 Global Fibrin Sealant (Human) Annual Sales by Country/Region (2020-2025)
4.2.2 Global Fibrin Sealant (Human) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Fibrin Sealant (Human) Sales Growth
4.4 APAC Fibrin Sealant (Human) Sales Growth
4.5 Europe Fibrin Sealant (Human) Sales Growth
4.6 Middle East & Africa Fibrin Sealant (Human) Sales Growth
5 AMERICAS
5.1 Americas Fibrin Sealant (Human) Sales by Country
5.1.1 Americas Fibrin Sealant (Human) Sales by Country (2020-2025)
5.1.2 Americas Fibrin Sealant (Human) Revenue by Country (2020-2025)
5.2 Americas Fibrin Sealant (Human) Sales by Type (2020-2025)
5.3 Americas Fibrin Sealant (Human) Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Fibrin Sealant (Human) Sales by Region
6.1.1 APAC Fibrin Sealant (Human) Sales by Region (2020-2025)
6.1.2 APAC Fibrin Sealant (Human) Revenue by Region (2020-2025)
6.2 APAC Fibrin Sealant (Human) Sales by Type (2020-2025)
6.3 APAC Fibrin Sealant (Human) Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Fibrin Sealant (Human) by Country
7.1.1 Europe Fibrin Sealant (Human) Sales by Country (2020-2025)
7.1.2 Europe Fibrin Sealant (Human) Revenue by Country (2020-2025)
7.2 Europe Fibrin Sealant (Human) Sales by Type (2020-2025)
7.3 Europe Fibrin Sealant (Human) Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Fibrin Sealant (Human) by Country
8.1.1 Middle East & Africa Fibrin Sealant (Human) Sales by Country (2020-2025)
8.1.2 Middle East & Africa Fibrin Sealant (Human) Revenue by Country (2020-2025)
8.2 Middle East & Africa Fibrin Sealant (Human) Sales by Type (2020-2025)
8.3 Middle East & Africa Fibrin Sealant (Human) Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Fibrin Sealant (Human)
10.3 Manufacturing Process Analysis of Fibrin Sealant (Human)
10.4 Industry Chain Structure of Fibrin Sealant (Human)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Fibrin Sealant (Human) Distributors
11.3 Fibrin Sealant (Human) Customer
12 WORLD FORECAST REVIEW FOR FIBRIN SEALANT (HUMAN) BY GEOGRAPHIC REGION
12.1 Global Fibrin Sealant (Human) Market Size Forecast by Region
12.1.1 Global Fibrin Sealant (Human) Forecast by Region (2026-2031)
12.1.2 Global Fibrin Sealant (Human) Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Fibrin Sealant (Human) Forecast by Type (2026-2031)
12.7 Global Fibrin Sealant (Human) Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Fibrin Sealant (Human) Product Portfolios and Specifications
13.1.3 Baxter Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Fibrin Sealant (Human) Product Portfolios and Specifications
13.2.3 CSL Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 Bayer
13.3.1 Bayer Company Information
13.3.2 Bayer Fibrin Sealant (Human) Product Portfolios and Specifications
13.3.3 Bayer Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bayer Main Business Overview
13.3.5 Bayer Latest Developments
13.4 Grifols
13.4.1 Grifols Company Information
13.4.2 Grifols Fibrin Sealant (Human) Product Portfolios and Specifications
13.4.3 Grifols Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Grifols Main Business Overview
13.4.5 Grifols Latest Developments
13.5 Octapharma
13.5.1 Octapharma Company Information
13.5.2 Octapharma Fibrin Sealant (Human) Product Portfolios and Specifications
13.5.3 Octapharma Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Octapharma Main Business Overview
13.5.5 Octapharma Latest Developments
13.6 Shanghai RAAS
13.6.1 Shanghai RAAS Company Information
13.6.2 Shanghai RAAS Fibrin Sealant (Human) Product Portfolios and Specifications
13.6.3 Shanghai RAAS Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Shanghai RAAS Main Business Overview
13.6.5 Shanghai RAAS Latest Developments
13.7 Hualan Biological
13.7.1 Hualan Biological Company Information
13.7.2 Hualan Biological Fibrin Sealant (Human) Product Portfolios and Specifications
13.7.3 Hualan Biological Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hualan Biological Main Business Overview
13.7.5 Hualan Biological Latest Developments
13.8 Immuno
13.8.1 Immuno Company Information
13.8.2 Immuno Fibrin Sealant (Human) Product Portfolios and Specifications
13.8.3 Immuno Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Immuno Main Business Overview
13.8.5 Immuno Latest Developments
13.9 Behringwerke
13.9.1 Behringwerke Company Information
13.9.2 Behringwerke Fibrin Sealant (Human) Product Portfolios and Specifications
13.9.3 Behringwerke Fibrin Sealant (Human) Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Behringwerke Main Business Overview
13.9.5 Behringwerke Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pet Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pet Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Nasal Administration
Table 4. Major Players of Injection
Table 5. Major Players of Other
Table 6. Global Pet Vaccine Sales by Type (2020-2025) & (K Doses)
Table 7. Global Pet Vaccine Sales Market Share by Type (2020-2025)
Table 8. Global Pet Vaccine Revenue by Type (2020-2025) & ($ million)
Table 9. Global Pet Vaccine Revenue Market Share by Type (2020-2025)
Table 10. Global Pet Vaccine Sale Price by Type (2020-2025) & (USD/Dose)
Table 11. Global Pet Vaccine Sale by Application (2020-2025) & (K Doses)
Table 12. Global Pet Vaccine Sale Market Share by Application (2020-2025)
Table 13. Global Pet Vaccine Revenue by Application (2020-2025) & ($ million)
Table 14. Global Pet Vaccine Revenue Market Share by Application (2020-2025)
Table 15. Global Pet Vaccine Sale Price by Application (2020-2025) & (USD/Dose)
Table 16. Global Pet Vaccine Sales by Company (2020-2025) & (K Doses)
Table 17. Global Pet Vaccine Sales Market Share by Company (2020-2025)
Table 18. Global Pet Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Pet Vaccine Revenue Market Share by Company (2020-2025)
Table 20. Global Pet Vaccine Sale Price by Company (2020-2025) & (USD/Dose)
Table 21. Key Manufacturers Pet Vaccine Producing Area Distribution and Sales Area
Table 22. Players Pet Vaccine Products Offered
Table 23. Pet Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Pet Vaccine Sales by Geographic Region (2020-2025) & (K Doses)
Table 27. Global Pet Vaccine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Pet Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Pet Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Pet Vaccine Sales by Country/Region (2020-2025) & (K Doses)
Table 31. Global Pet Vaccine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Pet Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Pet Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Pet Vaccine Sales by Country (2020-2025) & (K Doses)
Table 35. Americas Pet Vaccine Sales Market Share by Country (2020-2025)
Table 36. Americas Pet Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Pet Vaccine Sales by Type (2020-2025) & (K Doses)
Table 38. Americas Pet Vaccine Sales by Application (2020-2025) & (K Doses)
Table 39. APAC Pet Vaccine Sales by Region (2020-2025) & (K Doses)
Table 40. APAC Pet Vaccine Sales Market Share by Region (2020-2025)
Table 41. APAC Pet Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Pet Vaccine Sales by Type (2020-2025) & (K Doses)
Table 43. APAC Pet Vaccine Sales by Application (2020-2025) & (K Doses)
Table 44. Europe Pet Vaccine Sales by Country (2020-2025) & (K Doses)
Table 45. Europe Pet Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Pet Vaccine Sales by Type (2020-2025) & (K Doses)
Table 47. Europe Pet Vaccine Sales by Application (2020-2025) & (K Doses)
Table 48. Middle East & Africa Pet Vaccine Sales by Country (2020-2025) & (K Doses)
Table 49. Middle East & Africa Pet Vaccine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Pet Vaccine Sales by Type (2020-2025) & (K Doses)
Table 51. Middle East & Africa Pet Vaccine Sales by Application (2020-2025) & (K Doses)
Table 52. Key Market Drivers & Growth Opportunities of Pet Vaccine
Table 53. Key Market Challenges & Risks of Pet Vaccine
Table 54. Key Industry Trends of Pet Vaccine
Table 55. Pet Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Pet Vaccine Distributors List
Table 58. Pet Vaccine Customer List
Table 59. Global Pet Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 60. Global Pet Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Pet Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 62. Americas Pet Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Pet Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 64. APAC Pet Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Pet Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 66. Europe Pet Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Pet Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 68. Middle East & Africa Pet Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Pet Vaccine Sales Forecast by Type (2026-2031) & (K Doses)
Table 70. Global Pet Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Pet Vaccine Sales Forecast by Application (2026-2031) & (K Doses)
Table 72. Global Pet Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Boehringer Ingelheim Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Boehringer Ingelheim Pet Vaccine Product Portfolios and Specifications
Table 75. Boehringer Ingelheim Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 76. Boehringer Ingelheim Main Business
Table 77. Boehringer Ingelheim Latest Developments
Table 78. Zoetis Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Zoetis Pet Vaccine Product Portfolios and Specifications
Table 80. Zoetis Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 81. Zoetis Main Business
Table 82. Zoetis Latest Developments
Table 83. Elanco Animal Health Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Elanco Animal Health Pet Vaccine Product Portfolios and Specifications
Table 85. Elanco Animal Health Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 86. Elanco Animal Health Main Business
Table 87. Elanco Animal Health Latest Developments
Table 88. Merck Animal Health Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck Animal Health Pet Vaccine Product Portfolios and Specifications
Table 90. Merck Animal Health Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 91. Merck Animal Health Main Business
Table 92. Merck Animal Health Latest Developments
Table 93. Virbac Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Virbac Pet Vaccine Product Portfolios and Specifications
Table 95. Virbac Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 96. Virbac Main Business
Table 97. Virbac Latest Developments
Table 98. Dechra Veterinary Products Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Dechra Veterinary Products Pet Vaccine Product Portfolios and Specifications
Table 100. Dechra Veterinary Products Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 101. Dechra Veterinary Products Main Business
Table 102. Dechra Veterinary Products Latest Developments
Table 103. Ceva Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Ceva Pet Vaccine Product Portfolios and Specifications
Table 105. Ceva Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 106. Ceva Main Business
Table 107. Ceva Latest Developments
Table 108. Vetoquinol Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Vetoquinol Pet Vaccine Product Portfolios and Specifications
Table 110. Vetoquinol Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 111. Vetoquinol Main Business
Table 112. Vetoquinol Latest Developments
Table 113. Meiji Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Meiji Pet Vaccine Product Portfolios and Specifications
Table 115. Meiji Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 116. Meiji Main Business
Table 117. Meiji Latest Developments
Table 118. Ouro Fino Saude Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Ouro Fino Saude Pet Vaccine Product Portfolios and Specifications
Table 120. Ouro Fino Saude Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 121. Ouro Fino Saude Main Business
Table 122. Ouro Fino Saude Latest Developments
Table 123. Animalcare Group Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Animalcare Group Pet Vaccine Product Portfolios and Specifications
Table 125. Animalcare Group Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 126. Animalcare Group Main Business
Table 127. Animalcare Group Latest Developments
Table 128. Parnell Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Parnell Pet Vaccine Product Portfolios and Specifications
Table 130. Parnell Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 131. Parnell Main Business
Table 132. Parnell Latest Developments
Table 133. CAHIC Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. CAHIC Pet Vaccine Product Portfolios and Specifications
Table 135. CAHIC Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 136. CAHIC Main Business
Table 137. CAHIC Latest Developments
Table 138. Ringpu Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Ringpu Pet Vaccine Product Portfolios and Specifications
Table 140. Ringpu Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 141. Ringpu Main Business
Table 142. Ringpu Latest Developments
Table 143. Jinyu Group Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 144. Jinyu Group Pet Vaccine Product Portfolios and Specifications
Table 145. Jinyu Group Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 146. Jinyu Group Main Business
Table 147. Jinyu Group Latest Developments
Table 148. Keqian Biology Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 149. Keqian Biology Pet Vaccine Product Portfolios and Specifications
Table 150. Keqian Biology Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 151. Keqian Biology Main Business
Table 152. Keqian Biology Latest Developments
Table 153. Kyoritsu Seiyaku Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 154. Kyoritsu Seiyaku Pet Vaccine Product Portfolios and Specifications
Table 155. Kyoritsu Seiyaku Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 156. Kyoritsu Seiyaku Main Business
Table 157. Kyoritsu Seiyaku Latest Developments
Table 1. Pet Vaccine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Pet Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Nasal Administration
Table 4. Major Players of Injection
Table 5. Major Players of Other
Table 6. Global Pet Vaccine Sales by Type (2020-2025) & (K Doses)
Table 7. Global Pet Vaccine Sales Market Share by Type (2020-2025)
Table 8. Global Pet Vaccine Revenue by Type (2020-2025) & ($ million)
Table 9. Global Pet Vaccine Revenue Market Share by Type (2020-2025)
Table 10. Global Pet Vaccine Sale Price by Type (2020-2025) & (USD/Dose)
Table 11. Global Pet Vaccine Sale by Application (2020-2025) & (K Doses)
Table 12. Global Pet Vaccine Sale Market Share by Application (2020-2025)
Table 13. Global Pet Vaccine Revenue by Application (2020-2025) & ($ million)
Table 14. Global Pet Vaccine Revenue Market Share by Application (2020-2025)
Table 15. Global Pet Vaccine Sale Price by Application (2020-2025) & (USD/Dose)
Table 16. Global Pet Vaccine Sales by Company (2020-2025) & (K Doses)
Table 17. Global Pet Vaccine Sales Market Share by Company (2020-2025)
Table 18. Global Pet Vaccine Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Pet Vaccine Revenue Market Share by Company (2020-2025)
Table 20. Global Pet Vaccine Sale Price by Company (2020-2025) & (USD/Dose)
Table 21. Key Manufacturers Pet Vaccine Producing Area Distribution and Sales Area
Table 22. Players Pet Vaccine Products Offered
Table 23. Pet Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Pet Vaccine Sales by Geographic Region (2020-2025) & (K Doses)
Table 27. Global Pet Vaccine Sales Market Share Geographic Region (2020-2025)
Table 28. Global Pet Vaccine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Pet Vaccine Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Pet Vaccine Sales by Country/Region (2020-2025) & (K Doses)
Table 31. Global Pet Vaccine Sales Market Share by Country/Region (2020-2025)
Table 32. Global Pet Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Pet Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Pet Vaccine Sales by Country (2020-2025) & (K Doses)
Table 35. Americas Pet Vaccine Sales Market Share by Country (2020-2025)
Table 36. Americas Pet Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Pet Vaccine Sales by Type (2020-2025) & (K Doses)
Table 38. Americas Pet Vaccine Sales by Application (2020-2025) & (K Doses)
Table 39. APAC Pet Vaccine Sales by Region (2020-2025) & (K Doses)
Table 40. APAC Pet Vaccine Sales Market Share by Region (2020-2025)
Table 41. APAC Pet Vaccine Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Pet Vaccine Sales by Type (2020-2025) & (K Doses)
Table 43. APAC Pet Vaccine Sales by Application (2020-2025) & (K Doses)
Table 44. Europe Pet Vaccine Sales by Country (2020-2025) & (K Doses)
Table 45. Europe Pet Vaccine Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Pet Vaccine Sales by Type (2020-2025) & (K Doses)
Table 47. Europe Pet Vaccine Sales by Application (2020-2025) & (K Doses)
Table 48. Middle East & Africa Pet Vaccine Sales by Country (2020-2025) & (K Doses)
Table 49. Middle East & Africa Pet Vaccine Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Pet Vaccine Sales by Type (2020-2025) & (K Doses)
Table 51. Middle East & Africa Pet Vaccine Sales by Application (2020-2025) & (K Doses)
Table 52. Key Market Drivers & Growth Opportunities of Pet Vaccine
Table 53. Key Market Challenges & Risks of Pet Vaccine
Table 54. Key Industry Trends of Pet Vaccine
Table 55. Pet Vaccine Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Pet Vaccine Distributors List
Table 58. Pet Vaccine Customer List
Table 59. Global Pet Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 60. Global Pet Vaccine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Pet Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 62. Americas Pet Vaccine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Pet Vaccine Sales Forecast by Region (2026-2031) & (K Doses)
Table 64. APAC Pet Vaccine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Pet Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 66. Europe Pet Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Pet Vaccine Sales Forecast by Country (2026-2031) & (K Doses)
Table 68. Middle East & Africa Pet Vaccine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Pet Vaccine Sales Forecast by Type (2026-2031) & (K Doses)
Table 70. Global Pet Vaccine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Pet Vaccine Sales Forecast by Application (2026-2031) & (K Doses)
Table 72. Global Pet Vaccine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Boehringer Ingelheim Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 74. Boehringer Ingelheim Pet Vaccine Product Portfolios and Specifications
Table 75. Boehringer Ingelheim Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 76. Boehringer Ingelheim Main Business
Table 77. Boehringer Ingelheim Latest Developments
Table 78. Zoetis Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Zoetis Pet Vaccine Product Portfolios and Specifications
Table 80. Zoetis Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 81. Zoetis Main Business
Table 82. Zoetis Latest Developments
Table 83. Elanco Animal Health Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Elanco Animal Health Pet Vaccine Product Portfolios and Specifications
Table 85. Elanco Animal Health Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 86. Elanco Animal Health Main Business
Table 87. Elanco Animal Health Latest Developments
Table 88. Merck Animal Health Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck Animal Health Pet Vaccine Product Portfolios and Specifications
Table 90. Merck Animal Health Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 91. Merck Animal Health Main Business
Table 92. Merck Animal Health Latest Developments
Table 93. Virbac Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Virbac Pet Vaccine Product Portfolios and Specifications
Table 95. Virbac Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 96. Virbac Main Business
Table 97. Virbac Latest Developments
Table 98. Dechra Veterinary Products Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Dechra Veterinary Products Pet Vaccine Product Portfolios and Specifications
Table 100. Dechra Veterinary Products Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 101. Dechra Veterinary Products Main Business
Table 102. Dechra Veterinary Products Latest Developments
Table 103. Ceva Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Ceva Pet Vaccine Product Portfolios and Specifications
Table 105. Ceva Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 106. Ceva Main Business
Table 107. Ceva Latest Developments
Table 108. Vetoquinol Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Vetoquinol Pet Vaccine Product Portfolios and Specifications
Table 110. Vetoquinol Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 111. Vetoquinol Main Business
Table 112. Vetoquinol Latest Developments
Table 113. Meiji Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Meiji Pet Vaccine Product Portfolios and Specifications
Table 115. Meiji Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 116. Meiji Main Business
Table 117. Meiji Latest Developments
Table 118. Ouro Fino Saude Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Ouro Fino Saude Pet Vaccine Product Portfolios and Specifications
Table 120. Ouro Fino Saude Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 121. Ouro Fino Saude Main Business
Table 122. Ouro Fino Saude Latest Developments
Table 123. Animalcare Group Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Animalcare Group Pet Vaccine Product Portfolios and Specifications
Table 125. Animalcare Group Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 126. Animalcare Group Main Business
Table 127. Animalcare Group Latest Developments
Table 128. Parnell Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. Parnell Pet Vaccine Product Portfolios and Specifications
Table 130. Parnell Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 131. Parnell Main Business
Table 132. Parnell Latest Developments
Table 133. CAHIC Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. CAHIC Pet Vaccine Product Portfolios and Specifications
Table 135. CAHIC Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 136. CAHIC Main Business
Table 137. CAHIC Latest Developments
Table 138. Ringpu Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Ringpu Pet Vaccine Product Portfolios and Specifications
Table 140. Ringpu Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 141. Ringpu Main Business
Table 142. Ringpu Latest Developments
Table 143. Jinyu Group Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 144. Jinyu Group Pet Vaccine Product Portfolios and Specifications
Table 145. Jinyu Group Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 146. Jinyu Group Main Business
Table 147. Jinyu Group Latest Developments
Table 148. Keqian Biology Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 149. Keqian Biology Pet Vaccine Product Portfolios and Specifications
Table 150. Keqian Biology Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 151. Keqian Biology Main Business
Table 152. Keqian Biology Latest Developments
Table 153. Kyoritsu Seiyaku Basic Information, Pet Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 154. Kyoritsu Seiyaku Pet Vaccine Product Portfolios and Specifications
Table 155. Kyoritsu Seiyaku Pet Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2025)
Table 156. Kyoritsu Seiyaku Main Business
Table 157. Kyoritsu Seiyaku Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pet Vaccine
Figure 2. Pet Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Vaccine Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Pet Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pet Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pet Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Pet Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Nasal Administration
Figure 12. Product Picture of Injection
Figure 13. Product Picture of Other
Figure 14. Global Pet Vaccine Sales Market Share by Type in 2025
Figure 15. Global Pet Vaccine Revenue Market Share by Type (2020-2025)
Figure 16. Pet Vaccine Consumed in Cat
Figure 17. Global Pet Vaccine Market: Cat (2020-2025) & (K Doses)
Figure 18. Pet Vaccine Consumed in Dog
Figure 19. Global Pet Vaccine Market: Dog (2020-2025) & (K Doses)
Figure 20. Pet Vaccine Consumed in Other
Figure 21. Global Pet Vaccine Market: Other (2020-2025) & (K Doses)
Figure 22. Global Pet Vaccine Sale Market Share by Application (2024)
Figure 23. Global Pet Vaccine Revenue Market Share by Application in 2025
Figure 24. Pet Vaccine Sales by Company in 2025 (K Doses)
Figure 25. Global Pet Vaccine Sales Market Share by Company in 2025
Figure 26. Pet Vaccine Revenue by Company in 2025 ($ millions)
Figure 27. Global Pet Vaccine Revenue Market Share by Company in 2025
Figure 28. Global Pet Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Pet Vaccine Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Pet Vaccine Sales 2020-2025 (K Doses)
Figure 31. Americas Pet Vaccine Revenue 2020-2025 ($ millions)
Figure 32. APAC Pet Vaccine Sales 2020-2025 (K Doses)
Figure 33. APAC Pet Vaccine Revenue 2020-2025 ($ millions)
Figure 34. Europe Pet Vaccine Sales 2020-2025 (K Doses)
Figure 35. Europe Pet Vaccine Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Pet Vaccine Sales 2020-2025 (K Doses)
Figure 37. Middle East & Africa Pet Vaccine Revenue 2020-2025 ($ millions)
Figure 38. Americas Pet Vaccine Sales Market Share by Country in 2025
Figure 39. Americas Pet Vaccine Revenue Market Share by Country (2020-2025)
Figure 40. Americas Pet Vaccine Sales Market Share by Type (2020-2025)
Figure 41. Americas Pet Vaccine Sales Market Share by Application (2020-2025)
Figure 42. United States Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Pet Vaccine Sales Market Share by Region in 2025
Figure 47. APAC Pet Vaccine Revenue Market Share by Region (2020-2025)
Figure 48. APAC Pet Vaccine Sales Market Share by Type (2020-2025)
Figure 49. APAC Pet Vaccine Sales Market Share by Application (2020-2025)
Figure 50. China Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. India Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Pet Vaccine Sales Market Share by Country in 2025
Figure 58. Europe Pet Vaccine Revenue Market Share by Country (2020-2025)
Figure 59. Europe Pet Vaccine Sales Market Share by Type (2020-2025)
Figure 60. Europe Pet Vaccine Sales Market Share by Application (2020-2025)
Figure 61. Germany Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. France Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Pet Vaccine Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Pet Vaccine Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Pet Vaccine Sales Market Share by Application (2020-2025)
Figure 69. Egypt Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Pet Vaccine in 2025
Figure 75. Manufacturing Process Analysis of Pet Vaccine
Figure 76. Industry Chain Structure of Pet Vaccine
Figure 77. Channels of Distribution
Figure 78. Global Pet Vaccine Sales Market Forecast by Region (2026-2031)
Figure 79. Global Pet Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Pet Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Pet Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Pet Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Pet Vaccine Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Pet Vaccine
Figure 2. Pet Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Vaccine Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Pet Vaccine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Pet Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Pet Vaccine Sales Market Share by Country/Region (2024)
Figure 10. Pet Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Nasal Administration
Figure 12. Product Picture of Injection
Figure 13. Product Picture of Other
Figure 14. Global Pet Vaccine Sales Market Share by Type in 2025
Figure 15. Global Pet Vaccine Revenue Market Share by Type (2020-2025)
Figure 16. Pet Vaccine Consumed in Cat
Figure 17. Global Pet Vaccine Market: Cat (2020-2025) & (K Doses)
Figure 18. Pet Vaccine Consumed in Dog
Figure 19. Global Pet Vaccine Market: Dog (2020-2025) & (K Doses)
Figure 20. Pet Vaccine Consumed in Other
Figure 21. Global Pet Vaccine Market: Other (2020-2025) & (K Doses)
Figure 22. Global Pet Vaccine Sale Market Share by Application (2024)
Figure 23. Global Pet Vaccine Revenue Market Share by Application in 2025
Figure 24. Pet Vaccine Sales by Company in 2025 (K Doses)
Figure 25. Global Pet Vaccine Sales Market Share by Company in 2025
Figure 26. Pet Vaccine Revenue by Company in 2025 ($ millions)
Figure 27. Global Pet Vaccine Revenue Market Share by Company in 2025
Figure 28. Global Pet Vaccine Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Pet Vaccine Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Pet Vaccine Sales 2020-2025 (K Doses)
Figure 31. Americas Pet Vaccine Revenue 2020-2025 ($ millions)
Figure 32. APAC Pet Vaccine Sales 2020-2025 (K Doses)
Figure 33. APAC Pet Vaccine Revenue 2020-2025 ($ millions)
Figure 34. Europe Pet Vaccine Sales 2020-2025 (K Doses)
Figure 35. Europe Pet Vaccine Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Pet Vaccine Sales 2020-2025 (K Doses)
Figure 37. Middle East & Africa Pet Vaccine Revenue 2020-2025 ($ millions)
Figure 38. Americas Pet Vaccine Sales Market Share by Country in 2025
Figure 39. Americas Pet Vaccine Revenue Market Share by Country (2020-2025)
Figure 40. Americas Pet Vaccine Sales Market Share by Type (2020-2025)
Figure 41. Americas Pet Vaccine Sales Market Share by Application (2020-2025)
Figure 42. United States Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Pet Vaccine Sales Market Share by Region in 2025
Figure 47. APAC Pet Vaccine Revenue Market Share by Region (2020-2025)
Figure 48. APAC Pet Vaccine Sales Market Share by Type (2020-2025)
Figure 49. APAC Pet Vaccine Sales Market Share by Application (2020-2025)
Figure 50. China Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 54. India Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Pet Vaccine Sales Market Share by Country in 2025
Figure 58. Europe Pet Vaccine Revenue Market Share by Country (2020-2025)
Figure 59. Europe Pet Vaccine Sales Market Share by Type (2020-2025)
Figure 60. Europe Pet Vaccine Sales Market Share by Application (2020-2025)
Figure 61. Germany Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 62. France Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Pet Vaccine Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Pet Vaccine Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Pet Vaccine Sales Market Share by Application (2020-2025)
Figure 69. Egypt Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Pet Vaccine Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Pet Vaccine in 2025
Figure 75. Manufacturing Process Analysis of Pet Vaccine
Figure 76. Industry Chain Structure of Pet Vaccine
Figure 77. Channels of Distribution
Figure 78. Global Pet Vaccine Sales Market Forecast by Region (2026-2031)
Figure 79. Global Pet Vaccine Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Pet Vaccine Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Pet Vaccine Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Pet Vaccine Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Pet Vaccine Revenue Market Share Forecast by Application (2026-2031)
